Return to Statistics Toolbox

Dot Plot analysis for Study ST003484

Select one or more experimental factors for control and test groups. The members of each group should be DIFFERENT.
Control(s)Experimental factorTest(s)
Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells (3)
x-axis labels ?: Show a single class:
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Use:   Maximum # of individual metabolites to display:
Group by:   Maximum # of (most significant) metabolites per class to use in group calculation:
Analysis:Combine data for all analyses?:     

  logo